As physician shortages and burnout threaten the patient experience in oncology, The US Oncology Network works to scale ...

Although AI can support complex oncology decision-making, physician judgment remains critical to ensuring safe, ...

A detailed analysis of T-cell redirecting therapies in oncology, comparing the mechanisms of bispecific antibodies and CAR T ...

Nearly half of people diagnosed with advanced cancer over a recent 5-year period did not undergo next-generation sequencing, according to results of a retrospective cohort study.Rates improved over ...

Medically integrated dispensing improves affordability, adherence, and toxicity management via embedded pharmacy teams, ...

Florida Cancer Specialists & Research Institute, LLC is again partnering with Research to Practice® for the Fifth Annual ...

As the health care landscape evolves, it is necessary that we adapt to optimally address existing and emerging challenges. One omnipresent challenge is designing care delivery models that are both ...

A growing debate over the role of biomarkers in drug approvals is set to take center stage at the Clinical Trials in Oncology West Coast conference in San Diego. Clinicians argue for broader use of ...

Bristol-Myers Squibb (NYSE:BMY) expanded its collaboration with Foundation Medicine to develop a next-generation sequencing ...

Meridian Funds, managed by ArrowMark Partners, released its first-quarter 2026 investor letter for “Meridian Small Cap Growth ...

Gilead has struck a deal to buy Germany-based Tubulis for $3.15 billion upfront and up to $1.85 billion in milestones, securing an antibody-drug conjugate (ADC) candidate that is racing toward pivotal ...